Activ / February 1, 2021

INDIBA takes a new revolutionary approach for pain management

Spain: Barcelona, February 1st, 2021 – INDIBA announces the launch of OKTO, a radiofrequency equipment with a stable 448 kHz current, perfect for treating acute and chronic pain, based on high-frequency neuromodulation of pain and metabolic stimulation of biological tissues.

“This hands-free equipment is a revolutionary approach for pain management. It improves musculoskeletal and joint pain, such as neuropathies, discopathies, osteoarthritis, osteochondrosis and post-traumatic injuries,” says Remco Schmitz, INDIBA CEO.

“Additionally, it will help clinics to save time and resources during consultation while offering the INDIBA guarantee of results on pain management,” says Diederik van Goor, ACTIV business unit leader.

This device is at the heart of INDIBA solutions, made to remedy pain and targeted at chiropractors, physiotherapists, pain management specialists, physical therapists, sports medicine specialists, sports injury specialists, osteopaths, and physical rehab doctors.

The mechanism of action combines its scientifically proven enhancement of stem cell proliferation with the stimulation of neurovascular zones.
OKTO’s eight active channels will allow professionals to work superficially or with full depth, depending on the anatomical needs of each situation or pathology. It works effectively over the spine ganglions or over the peripheral nerve system to deliver an antineuralgic and antineuritic effect.

For more information about OKTO, please visit: www.indiba.com/products/okto/

INDIBA® is a global leader in the field of radiofrequency (RF) solutions for the physiotherapy, aesthetic and veterinary market, and is known all over the world for its scientific research spanning the last 35 years.